Skip to main content
Top
Published in: Rheumatology International 10/2012

01-10-2012 | Original Article

Pattern of bone mineral density in idiopathic male osteoporosis

Author: Michel Laroche

Published in: Rheumatology International | Issue 10/2012

Login to get access

Abstract

The mechanisms of male idiopathic osteoporosis are little known. We evaluated bone mineral loss by dual-energy X-ray absorptiometry and determined its cortical or trabecular nature in a cohort of men with idiopathic osteoporosis with fractures. Thirty-nine men (mean age 60 ± 13 years), with negative investigations for the cause of osteoporosis, were studied. All had fragility fractures: vertebral 51%, peripheral 25%, and both types 24%. Bone density was measured at the lumbar spine (L2-L4), total hip and whole body. The limb/axial skeleton (spine + hips) and hip/L2-L4 BMD ratios were calculated. Serum 25-hydroxy-vitamin D, PTH, bone alkaline phosphatase and CTX were measured. Bone mineral loss predominated at the lumbar spine (mean L2-L4 T-score −3 ± 0.93, mean total hip T-score −1.87 ± 0.75). Limb/axial skeleton and total hip/L2-L4 BMD were strongly correlated, but not hip and spine BMD. The ratio values were widely scattered, indicating markedly heterogeneous bone loss. Vitamin D, PTH, bone alkaline phosphatase and CTX levels did not differ between predominantly trabecular and cortical osteoporosis. Bone mineral density measurement in male idiopathic osteoporosis with fractures demonstrated that bone loss predominated in the spine and that it was very heterogeneous, principally affecting cortical or trabecular bone depending on the patient.
Literature
3.
5.
go back to reference Haney EM, Bliziotes MM (2008) Male osteoporosis: new insights in an understudied disease. Curr Opin Rheumatol 20:423–428PubMedCrossRef Haney EM, Bliziotes MM (2008) Male osteoporosis: new insights in an understudied disease. Curr Opin Rheumatol 20:423–428PubMedCrossRef
6.
go back to reference Boonen S, Kaufman JM, Goemare S et al (2001) The diagnosis and treatment of male osteoporosis: defining, assessing, and preventing skeletal fragility in men. Calcif Tissue Int 69:209–213CrossRef Boonen S, Kaufman JM, Goemare S et al (2001) The diagnosis and treatment of male osteoporosis: defining, assessing, and preventing skeletal fragility in men. Calcif Tissue Int 69:209–213CrossRef
7.
go back to reference Grisso JA, Chiu GY, Maislin G et al (1991) Risk factors for hip fractures in men: a preliminary study. Bone 8:865–868 Grisso JA, Chiu GY, Maislin G et al (1991) Risk factors for hip fractures in men: a preliminary study. Bone 8:865–868
8.
go back to reference Seeman E, Melton LJ, O’Fallon WM et al (1983) Risk factors for osteoporosis in men. Am J Med 75:977–983PubMedCrossRef Seeman E, Melton LJ, O’Fallon WM et al (1983) Risk factors for osteoporosis in men. Am J Med 75:977–983PubMedCrossRef
9.
go back to reference Seeman E, Bianchi G, Khosla S et al (2006) Bone fragility in men–where are we? Osteoporos Int 17:1577–1583PubMedCrossRef Seeman E, Bianchi G, Khosla S et al (2006) Bone fragility in men–where are we? Osteoporos Int 17:1577–1583PubMedCrossRef
10.
go back to reference Pietschmann P, Kudlacek S, Grisar J et al (2001) Bone turnover markers and sex hormones in men with idiopathic osteoporosis. Eur J Clin Invest 31:444–451PubMedCrossRef Pietschmann P, Kudlacek S, Grisar J et al (2001) Bone turnover markers and sex hormones in men with idiopathic osteoporosis. Eur J Clin Invest 31:444–451PubMedCrossRef
11.
go back to reference Lormeau C, Soudan B, d’Herbomez M et al (2004) Sex-hormone-binding globulin, estradiol, and bone turnover markers in male osteoporosis. Bone 34:933–939PubMedCrossRef Lormeau C, Soudan B, d’Herbomez M et al (2004) Sex-hormone-binding globulin, estradiol, and bone turnover markers in male osteoporosis. Bone 34:933–939PubMedCrossRef
12.
go back to reference Kurland ES, Rosen CJ, Cosman F et al (1997) Insulin-like growth factor-1 in men with idiopathic osteoporosis. J Clin Endocrinol Metab 82:2799–2805PubMedCrossRef Kurland ES, Rosen CJ, Cosman F et al (1997) Insulin-like growth factor-1 in men with idiopathic osteoporosis. J Clin Endocrinol Metab 82:2799–2805PubMedCrossRef
13.
go back to reference Cohen-Solal ME, Baudoin C, Omouri M et al (1998) Bone mass in middle-aged osteoporotic men and their relatives: familial effect. J Bone Miner Res 13:1909–1914PubMedCrossRef Cohen-Solal ME, Baudoin C, Omouri M et al (1998) Bone mass in middle-aged osteoporotic men and their relatives: familial effect. J Bone Miner Res 13:1909–1914PubMedCrossRef
14.
go back to reference Marshall D, Johnell O, Wedel H (1996) Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 312:1254–1259PubMedCrossRef Marshall D, Johnell O, Wedel H (1996) Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 312:1254–1259PubMedCrossRef
15.
go back to reference Schuit SC, Van Der Klift M, Weel AE (2004) Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam study. Bone 34:195–202PubMedCrossRef Schuit SC, Van Der Klift M, Weel AE (2004) Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam study. Bone 34:195–202PubMedCrossRef
16.
go back to reference Legrand E, Chappard D, Pascaretti C et al (1999) Bone mineral density and vertebral fractures in men. Osteoporos Int 10:265–270PubMedCrossRef Legrand E, Chappard D, Pascaretti C et al (1999) Bone mineral density and vertebral fractures in men. Osteoporos Int 10:265–270PubMedCrossRef
17.
go back to reference Mundy GR (1998) Remodelage osseux et mécanismes de la perte osseuse dans l’ostéoporose. In: Meunier PJ (ed) Ostéoporose: progrès dans le diagnostic et la prise en charge. Martin Dunitz Ltd, London, pp 17–36 Mundy GR (1998) Remodelage osseux et mécanismes de la perte osseuse dans l’ostéoporose. In: Meunier PJ (ed) Ostéoporose: progrès dans le diagnostic et la prise en charge. Martin Dunitz Ltd, London, pp 17–36
18.
go back to reference Melton LJ, Looker AC, Shepherd JA et al (2005) Osteoporosis assessment by whole body region vs. site specific DXA. Osteoporos Int 16:1558–1564PubMedCrossRef Melton LJ, Looker AC, Shepherd JA et al (2005) Osteoporosis assessment by whole body region vs. site specific DXA. Osteoporos Int 16:1558–1564PubMedCrossRef
19.
go back to reference Hangartner TN, Skugor M, Landoll JD et al (2000) Comparison of absorptiometry evaluations from total-body and local-regional skeletal scans. J Clin Densitom 3:215–225PubMedCrossRef Hangartner TN, Skugor M, Landoll JD et al (2000) Comparison of absorptiometry evaluations from total-body and local-regional skeletal scans. J Clin Densitom 3:215–225PubMedCrossRef
20.
go back to reference Chavassieux P, Meunier PJ (2001) Histomorphometric approach of bone loss in men. Calcif Tissue Int 69:209–213PubMedCrossRef Chavassieux P, Meunier PJ (2001) Histomorphometric approach of bone loss in men. Calcif Tissue Int 69:209–213PubMedCrossRef
21.
go back to reference Delichatsios HK, Lane JM, Rivlin RS (1995) Bone histomorphometry in men with spinal osteoporosis. Calcif Tissue Int 56:359–363PubMedCrossRef Delichatsios HK, Lane JM, Rivlin RS (1995) Bone histomorphometry in men with spinal osteoporosis. Calcif Tissue Int 56:359–363PubMedCrossRef
22.
go back to reference Pernow Y, Hauge EM, Linder K et al (2009) Bone histomorphometry in male with idiopathic osteoporosis. Calcif Tissue Int 84:430–438PubMedCrossRef Pernow Y, Hauge EM, Linder K et al (2009) Bone histomorphometry in male with idiopathic osteoporosis. Calcif Tissue Int 84:430–438PubMedCrossRef
23.
go back to reference Uzzan B, Campos J, Cucherat M et al (1996) Effects on bone mass of long term treatment with thyroid hormones: a meta analysis. J Clin Endocrinol Metab 81:4278–4289PubMedCrossRef Uzzan B, Campos J, Cucherat M et al (1996) Effects on bone mass of long term treatment with thyroid hormones: a meta analysis. J Clin Endocrinol Metab 81:4278–4289PubMedCrossRef
24.
go back to reference Christiansen P, Steiniche T, Brixen K et al (1997) Primary hyperparathyroidism: biochemical markers and bone mineral density at multiple skeletal sites in Danish patients. Bone 21:93–99PubMedCrossRef Christiansen P, Steiniche T, Brixen K et al (1997) Primary hyperparathyroidism: biochemical markers and bone mineral density at multiple skeletal sites in Danish patients. Bone 21:93–99PubMedCrossRef
25.
go back to reference Chiodini I, Carnevale V, Torlontano M (1998) Alterations of bone turnover and bone mass at different skeletal sites due to pure glucocorticoid excess: study in eumenorrheic patients with Cushing’s syndrome. J Clin Endocrinol Metab 83:1863–1867PubMedCrossRef Chiodini I, Carnevale V, Torlontano M (1998) Alterations of bone turnover and bone mass at different skeletal sites due to pure glucocorticoid excess: study in eumenorrheic patients with Cushing’s syndrome. J Clin Endocrinol Metab 83:1863–1867PubMedCrossRef
26.
go back to reference Lorentzon M, Mellström D, Haug E et al (2007) Smoking is associated with lower bone mineral density and reduced cortical thickness in young men. J Clin Endocrinol Metab 92:497–503PubMedCrossRef Lorentzon M, Mellström D, Haug E et al (2007) Smoking is associated with lower bone mineral density and reduced cortical thickness in young men. J Clin Endocrinol Metab 92:497–503PubMedCrossRef
Metadata
Title
Pattern of bone mineral density in idiopathic male osteoporosis
Author
Michel Laroche
Publication date
01-10-2012
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 10/2012
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-011-2076-7

Other articles of this Issue 10/2012

Rheumatology International 10/2012 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.